EUVIMEDEUVIMED entdecken
Crossref

LRRC45 promotes lung cancer proliferation and progression by enhancing c-MYC, slug, MMP2, and MMP9 expression

Qian Wang, Xin-Yan Liu, Xiao-Qi Zhang, Zheng-Xing Huo, Cheng-Yu Chen, Shi Chen, Cheng-Yong Liu, Jia Zhu, Shan-Shan Liu, Bing Lu

Advances in Medical Sciences · 2024

DOI: 10.1016/j.advms.2024.09.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Medical Sciences, 2024. Verfasst von Qian Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nan…. Hauptthemen laut MEDLINE: Lung Neoplasms, Cell Proliferation, Snail Family Transcription Factors, Proto-Oncogene Proteins c-myc. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The leucine-rich repeat-containing (LRRC) superfamily members are known for their significant roles in tumorigenesis and cellular proliferation. However, the specific regulatory role of LRRC45 in lung cancer remains unexplored. This study investigated the impact and underlying mechanisms of LRRC45 on the proliferative, migratory, and invasive capacities of lung adenocarcinoma (LUAD) cells, potentially identifying new targets for therapeutic intervention. MATERIAL AND METHODS: The importance of LRRC45 in lung cancer was analyzed using the online databases of UCSC Xena, TCGA, TISIDB, and UALCAN, whereas to detect target gene expression, we used the qRT-PCR, Western blot, and immunofluorescence confocal. The cell growth was monitored by colony formation assay and migration was examined by cell migration assay. Finally, a xenograft mouse tumor model using A549 ​cells was used to explore the in vivo effect of LRRC45 in lung cancer. RESULTS: Inhibition of LRRC45 expression led to a notable decrease in proliferation, migration, and invasion of A549 and H1299 ​cells. LRRC45 silencing significantly reduced the tumor volume and improved the mice's survival. Additionally, inhibition of LRRC45 expression dramatically suppressed c-MYC, Slug, MMP2, and MMP9 expression. Overexpression of c-MYC and/or Slug in the LRRC45-deficient cells can partially or totally restore the LRRC45 deficiency-suppressed growth. Moreover, the overexpression of MMP2 and/or MMP9 could partially or totally restore LRRC45 deficiency-reduced cell metastasis. CONCLUSIONS: LRRC45 could promote the proliferative, migrative, and invasive capacities of lung cancer cells by increasing c-MYC, Slug, MMP2, and MMP9 expression, indicating the therapeutic implications and potential significance of these pathways in lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCell ProliferationSnail Family Transcription FactorsProto-Oncogene Proteins c-mycMatrix Metalloproteinase 2Matrix Metalloproteinase 9HumansMiceAnimalsGene Expression Regulation, NeoplasticCell MovementDisease ProgressionXenograft Model Antitumor AssaysMice, Nude

Stichwörter der Autor:innen

BioinformaticsLRRC45Non-small cell lung cancerSlugc-MYC

Substanzen

Snail Family Transcription FactorsProto-Oncogene Proteins c-mycMatrix Metalloproteinase 2Matrix Metalloproteinase 9MMP2 protein, humanSNAI1 protein, humanMYC protein, humanMMP9 protein, human

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China; Department of Respiratory Medicine, Suqian Affil…
  • Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China.
  • Department of Respiratory Medicine, Suqian Affiliated Hospital of Nanjing University of Chinese Medicine, Suqian Hospital of Chinese Medicine, Suqian, Jiangsu, China. Electronic address: 15152424633@163.com.
  • Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Taicang Hospital of Traditional Chinese Medicine, Taicang, Jiangsu, China. Electronic address: tczyylb@163.com.

Zitieren

APA

Wang, Q., Liu, X. Y., Zhang, X. Q., Huo, Z. X., Chen, C. Y., Chen, S., Liu, C. Y., Zhu, J., Liu, S. S., & Lu, B. (2024). LRRC45 promotes lung cancer proliferation and progression by enhancing c-MYC, slug, MMP2, and MMP9 expression. Advances in Medical Sciences. https://doi.org/10.1016/j.advms.2024.09.007

Vancouver

Wang Q, Liu XY, Zhang XQ, Huo ZX, Chen CY, Chen S, et al. LRRC45 promotes lung cancer proliferation and progression by enhancing c-MYC, slug, MMP2, and MMP9 expression. Advances in Medical Sciences. 2024. doi:10.1016/j.advms.2024.09.007

BibTeX
@article{Wang2024,
  author = {Wang, Qian and Liu, Xin-Yan and Zhang, Xiao-Qi and Huo, Zheng-Xing and Chen, Cheng-Yu and Chen, Shi and Liu, Cheng-Yong and Zhu, Jia and Liu, Shan-Shan and Lu, Bing},
  title = {LRRC45 promotes lung cancer proliferation and progression by enhancing c-MYC, slug, MMP2, and MMP9 expression},
  journal = {Advances in Medical Sciences},
  year = {2024},
  doi = {10.1016/j.advms.2024.09.007}
}
Kostenlos starten →